항염증제제가 실험적 증식치료 모델의 조직 소견에 미치는 영향

참고문헌 (30)

1. 김현정, "실험적 프로로테라피 모델에서 다당류 농도에 따른 증식제 효과의 비교", Annals of Rehabilitation Medicine, 27(6), pp.21~940 (2003), 대한재활의학회
2. Abrahamsson SO, "Matrix metabolism and healing in the flexor tendon", 23, pp.1~51 (1991)
3. Bogatov VB, "The influence of a cyclooxygenase-1 inhibitor on injured and uninjured ligaments in the rat", 31, pp.574~576 (2003)
4. Botting RM, "Mechanism of action of acetaminophen: is there a cyclooxygenase 3?", 5, pp.202~210 (2000)
5. Chan BP, "Effects of basic fibroblast growth factor on early stages of tendon healing", 71, pp.513~518 (2000)
6. Di Paolo S, "High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells", 149, pp.2095~2106 (1996)
7. Dorman TA, "Refurbishing ligaments with prolotherapy", 9, pp.509~516 (1995)
8. Elder CL, "A cyclooxygenase-2 inhibitor impairs ligament healing in the rat", 29, pp.801~805 (2001)
9. Fernandez P, "A novel cyclo-oxygenase-2 inhibitor modulates catabolic and antiinflammatory mediators in osteoarthritis", 68, pp.417~421 (2004)
10. Flower R, "Effects of anti-inflammatory drugs on prostaglandin biosynthesis", 238, pp.104~106 (1972)
11. Frank C, "Collagen fibril diameters in the rabbit medial collateral ligament scar:A longer term assessment", 36, pp.261~269 (1997)
12. Gately S, "The contributions of cyclooxygenase-2 to tumor angiogenesis", 19, pp.19~27 (2000)
13. Manske PR, "Flexor tendon repair in vitro: a comparative histologic study of the rabbit, chicken, dog, and monkey.", 2, pp.39~48 (1984)
14. Gill SS, "Semitendinosus regrowth: biochemical, ultrastructural, and physiological characterization of the regenerate tendon.", 32, pp.1173~1381 (2004)
15. Hackett GS, "Ligament and tendon relaxation treated by prolotherapy", pp.17~18 (1993), Thomas Publisher
16. Hauser RA, "Prolo your pain away", pp.62~64 (1998), Beulah Land Press
17. Jack EA, "Experimental rupture of medial collateral ligament of the knee", 32, pp.396~402 (1950)
18. Lefkowith JB, "Cyclooxygenase-2 specificity and its clinical implications", 106 (1999)
19. Lipsky PE, "Role of cyclooxygenase-1 and 2 in health and disease", 28, pp.8~12 (1999)
20. Majima M, "Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants", 130, pp.641~649 (2000)
21. Needleman P, "The discovery and function of COX-2", 49, pp.6~8 (1997)
22. Netomo O, "Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes", 24, pp.1774~1779 (1997)
23. Ohgi S, "Glucose modulates growth of gingival fibroblasts and periodontal ligament cells:correlation with expression of basic fibroblast growth factor", 31, pp.579~588 (1996)
24. Reeves KD, "Basic science, clinical studies, and technique", pp.172~180 (2000), Hanley & Belfus
25. Reinhold D, "Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1) suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells", 28, pp.267~270 (1996)
26. Rudkin GH, "Growth factors in surgery", 97, pp.469~476 (1996)
27. Skjelbred P, "Acetylsalicylic acid versus paracetamol:effects on post-operative course", 12, pp.257~264 (1977)
28. Vane JR, "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs", 231, pp.232~235 (1971)
29. van Ryn J, "cyclooxygenase-2 inhibitors: pharmacology, clinical effects and therapeutic potential.", 6, pp.609~614 (1997)
30. Zhang F, "Effect of vascular endothelial growth factor on rat Achilles tendon healing", 112, pp.1613~1619 (2003)

관련 논문AI추천